[HTML][HTML] Hepatolithiasis: Epidemiology, presentation, classification and management of a complex disease
RV Motta, F Saffioti, VK Mavroeidis - World Journal of …, 2024 - ncbi.nlm.nih.gov
The term hepatolithiasis describes the presence of biliary stones within the intrahepatic bile
ducts, above the hilar confluence of the hepatic ducts. The disease is more prevalent in Asia …
ducts, above the hilar confluence of the hepatic ducts. The disease is more prevalent in Asia …
[HTML][HTML] Role of routine lymph node dissection alongside resection of intrahepatic cholangiocarcinoma: Systematic review and meta-analysis
M Atif, A Borakati, VK Mavroeidis - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND The global incidence of intrahepatic cholangiocarcinoma (ICCA) is soaring.
Due to often delayed presentation, only a narrow spectrum of the disease is usually …
Due to often delayed presentation, only a narrow spectrum of the disease is usually …
Perioperative and palliative systemic treatments for biliary tract cancer
H Taghizadeh, Y Dong… - … Advances in Medical …, 2024 - journals.sagepub.com
Due to the fact biliary tract cancer (BTC) is often diagnosed at an advanced stage, thus, not
eligible for resection, and due to the aggressive tumor biology, it is considered as one of the …
eligible for resection, and due to the aggressive tumor biology, it is considered as one of the …
[HTML][HTML] Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation
Simple Summary Cholangiocarcinoma (CCA) poses a substantial threat as it ranks as the
second most prevalent primary liver tumor. This review reports comprehensively describe …
second most prevalent primary liver tumor. This review reports comprehensively describe …
[HTML][HTML] Cost-effectiveness analysis of pembrolizumab in combination with chemotherapy compared with chemotherapy alone as first-line treatment for patients with …
Z Zheng, L Fang, H Cai - BMC cancer, 2023 - Springer
Objective The objective of this study is to evaluate the cost-effectiveness of adding
pembrolizumab to the standard first-line therapy of advanced biliary tract cancer (BTC) with …
pembrolizumab to the standard first-line therapy of advanced biliary tract cancer (BTC) with …
[HTML][HTML] Primary sclerosing cholangitis and cholangiocarcinoma: the 2023 practice guidance and future perspectives
F Saffioti, VK Mavroeidis - Hepatobiliary Surgery and Nutrition, 2024 - ncbi.nlm.nih.gov
Correspondence to: Vasileios K. Mavroeidis, MD, MSc, FRCS, FACS, FICS, MFSTEd, MICR.
Department of HPB Surgery, University Hospitals Bristol & Weston NHS Foundation Trust …
Department of HPB Surgery, University Hospitals Bristol & Weston NHS Foundation Trust …
Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis–a retrospective cohort study
C Schramm, A Sapuk, D Hoyer… - Zeitschrift für …, 2024 - thieme-connect.com
Background Patients with primary sclerosing cholangitis (PSC) carry increased risks for
malignancy, among which cholangiocarcinoma (CCA) is the most frequent. We aimed to …
malignancy, among which cholangiocarcinoma (CCA) is the most frequent. We aimed to …
Tumor de Klatskin-uma revisão de literatura
DA Pereira, FBN dos Santos… - … Journal of Health …, 2024 - ojs.brazilianjournals.com.br
O colangiocarcinoma hilar, comumente conhecido como tumor de Klatskin, é uma neoplasia
rara que acomete a junção dos ductos biliares intra-hepáticos. Sua incidência é baixa …
rara que acomete a junção dos ductos biliares intra-hepáticos. Sua incidência é baixa …